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which were unchanged (0.35 ± 0.52; p = 0.111. Thus: 1) at rest, degree of
RMW abnormality correlates generally with level of RMBF and 2) RMBF re-
sponse to adenosine (Ado). a measure of coronary flow reserve, correlates
with RWM response to dobutamine stress which depends at least in part on
augmentation of coronary flow.
10:45
1704-21 Comparative Relation of Neurohormonal Activation
to Hemodynamics in Primary or Precapillary
Secondary Pulmonary Hypertension
Nazzareno Galie, Maria L. Borgatti, Gianpaolo Ussia, Riccardo Parlangeli,
Stefano Boschi, Alberto Bargossi, Angelo Branzi, Bruno Magnani. Institute of
Cardiovascular Diseases, University of Bologna, Italy
Primary (PPH) or precapillary secondary (SPH) pulmonary hypertension show
similar hemodynamic abnormalities and an intense neurohormonal activa-
tion has been detected in both syndromes. Comparative analysis of the neu-
rohormonal profile and its relation to hemodynamics of patients with PPH
and SPH are not available. Plasma levels of atrial natriuretic peptide (ANP). al-
dosterone (ALD). renin activity (PRA). epinephrine (PE). norepinephrine (PNE)
and endothelin (ET) were assessed from the antecubital vein in 12 patients
with PPH and 7 patients with SPH (2 connective tissue disease, 2 chronic
thromboembolic, 3 closed atrial septal defect). Hemodynamics were mea-
sured by heart catheterization. Between PPH and SPH patients no differ-
ences were assessed on cardiac index (CII (2.2 ± 0.2 vs 2.3 ± 03 l/min/m2,
ns), mean pulmonary artery pressure (PAP) (55 ± 12 vs 58 ± 12 mmHg, ns),
pulmonary vascular resistance (PVR) (14 ± 6 vs 14 ± 4 RU, ns) right atrial
pressure IRAP) (4 ± 4 vs 8 ± 7 mmHg, p = 0.13) and mixed venous blood
oxygen saturation (vSat) (62 ± 7 vs 65 ± 9%, ns). Neurohormonal parameters
in patients with PPH and patients with SPH were as follows:
ANP ALD PRA PE PNE ET
Ipglmll lpg/mil (nglmllh) (pglmll (pg/mll (pg/ml)
PPH 203 ± 139 178 ± 132 1.8±2.1 351 ± 420 426 ± 343 4.5 ± 3.1
SPH 210 ± 110 220 ± 262 2.5 ± 4.0 268 ± 333 637 ± 720 69 ± 3.7
p ns ns ns ns ns ns
In patients with PPH, ET was correlated to RAP (r = 0.68, p < 0.02). to CI
(r = 0.66, P < 0.02) and to PVR (r = 0.65, p < 0.02) In patients with SPH, ET
was correlated to RAP (r = 0.96, P < 0.01). PNE was correlated to vSat (r =
-0.80, P < 0.03) and ALD was correlated to RAP Ir = 0.87, p < 0.02).
Conclusions: No differences were observed on plasma levels of neurohor-
mons between patients with PPH and SPH In patients with PPH hemody-
namic abnormalities were correlated only to ET plasma levels while in pa-
tients with SPH hemodynamics were correlated to ET. to PNE and to ALD
plasma levels. Neuroendocrine activation shows a different pattern of asso-
ciation with hemodynamic abnormalities in patients with PPH compared to
patients with SPH.
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1704-31 Relation of Neurohormonal Activation to Functional
Class in Patients with Primary or Precapillary
Secondary Pulmonary Hypertension
Nazzareno Galie, Maria L. Borgatti, Gianpaolo Ussia, Riccardo Parlangeli,
Stefano Boschi, Alberto Bargossi, Angelo Branzi, Bruno Magnani. Institute of
Cardiovascular Diseases, University of Bologna, Italy
Intense neurohormonal activation has been demonstrated in patients with
primary or precapillary secondary pulmonary hypertension (PH) but the rela-
tion of neurohormons to functional impairment is not well known. Plasma
levels of atrial natriuretic peptide (ANP). aldosterone (ALD), renin activity
(PRA). epinephrine (PE). norepinephrine (PNE) and endothelin (ET) were as-
sessed from the antecubital vein in 12 patients with primary PH, 7 pa-
tients with precapillary secondary PH (2 connective tissue disease, 2 chronic
thromboembolic, 3 closed atrial septal defect) and 10 control subjects.
Twelve patients were in NYHA functional class II (PH-II) and 7 in class III/IV
(PH-III/IV). Mean PA pressure (PAP), cardiac index (CI). pulmonary vascular
resistance (PVR) and right atrial pressure were assessed by heart catheteri-
zation:
PAP CI PVR RAP
(mmHg) (l/minlm2) (RU) (mmHg)
PH-II 53 ± 13 2.4 ± 0.4 12 ± 3 3±2
PH-III/IV 61 ±9 2.0 ± 05 18 ± 6 11 ±5
p 0.17 0.07 0009 00001
Neurohormons plasma levels in control subjects (C), PH-II and PH-III/IV pa-
tients were as follows:
ANP ALD PRA PE PNE ET
(pg/mll (pglml) (nglmllhl Ipglml) lpg/mil Ipglmll
C 58 ± 18 110± 65 0.7 ± 0.4 33 ± 19 220 ± 101 1.7 ± 0.3
PH-II 167 ± 96* 144 ± 102 15 ± 2.0 298 ± 263* 420 ± 294' 3.6 ± 1.4*
PH-III/IV 276 ± 153*t 209 ± 270 3.2 ± 3.9' 462 ± 524* 820 ± 693*t 8.4 ± 3.9*0
* p < 0.05 vs COp < 0.001 vo PH-II t P < 0.09 vs PH-II
Conclusions: Neurohormonal activation in primary or precapillary sec-
ondary PH is detectable also in patients without overt clinical and hemo-
dynamic signs of right heart failure (PH-II). Neurohormonal activation seems
to be progressive and is more severe in functional class III/IV patients. ET
shows the best statistically significant relation with functional impairment.
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1704-41 EDRF-mediated Increases in Conduit Artery
Distensibility are Impaired in Chronic Heart Failure
Mark W. Ramsey, Christopher J.H. Jones, Lisa A. Luddington, Malcolm J. Lewis,
Andrew H. Henderson. Cardiovascular Sciences Research Group, University of Wales
College of Medicine, Cardiff, U.K.
Chronic heart failure (CHF) is associated with reduced EDRF actiVity in resis-
tance arteries. A similar effect in conduit arteries would reduce their disten-
sibility and increase the load on the compromised heart. We measured pulse
wave velocity (PWV). inversely related to distensibility, in the right common
iliac artery (RCIA) during acetylcholine (ACh, endothelium-dependent dilator)
and adenosine (Ado, endothelium-independent dilator) infusion in 6 patients
with CHF (NYHA grades 2-3, EF <40%, age 50 ± 16 [SD] years, 4 men) and
9 normal subjects (N) (age 49 ± 6 years, 4 men). CHF was due to dilated car-
diomyopathy (with normal blood pressure, cholesterol, glucose, and coro-
nary angiograms). PINY. measured from the pressure pulse delay between
2 transducers 5 cm apart, was measured during infusions proximal (P) and
distal (D)to the RCIA segment studied. We corrected for BP and other down-
stream effects by subtracting D from P effects. At baseline, PWV was similar
in the two groups (CHF 8.7 ± 1.1; N 9.1 ± 1.5 ms-1). ACh (10-7,10-6,10-5
mol/L) induced dose-dependent reductions in PWV (-5, -15, -25%) in nor-
mals but no change (+ 2, +2, -3%) in CHF (p = 0.0013). Ado (2 x 10-7, 2 x
10-6,2 x 10-5 mol/U induced similar dose-related reductions in PWV in N
(-5, -12, -24%) and in CHF (-1, -12, -14%, NS). These data indicate that
conduit artery distensibility is increased by ACh-stimulated EDRF activity in
normal subjects but not in patients with CHF. This suggests that physiologi-
cal EDRF-mediated increases in distensibility, as occur during exercise, may
be impaired in CHF despite normal resting distensibility.
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1704-51 Adenosine Dilates Conductance and Resistance
Vessels in Denervated Human Coronary Arteries and
is more Potent than Dipyridamole
Tony M. Chou, Thomas M. Amidon, Krishnankutty Sudhir, Cindy S. Klinski, Debra
M. Lau, Teresa DeMarco, Kanu Chatterjee, Elias H. Botvinik. University of California,
San Francisco, CA
Adenosine and dipyridamole are coronary vasodilators who act primarily on
resistance vessels. Vascular response in the denervated heart are not well
understood. To examine this question, coronary hemodynamic changes in re-
sponse to standard vasodilators were assessed in eleven heart transplanted
patients using simultaneously a 4.3F, 30 MHz ultrasound imaging catheter
(CVIS) over a 0.014" Doppler gUidewire (Cardiometries). Measures of average
peak velocity IAPV) and cross-sectional area (CSA) were used to calculate vol-
umetric flow during intravenous infusions of the endothelium independent
vasodilators adenosine 1140 j<glkg/min over 4 minutes) and dipyridamole
1140 /Lg/kg/min over 4 minutes). Volumetric coronary blood flow (CBF) was
calculated using the previously validated relationship CBF = 0.47 x CSA x
APV. Flow reserve was assessed as a ratio of maximal pharmacologically-
induced flow to steady baseline flow prior to infusion. Increase in coronary
average peak velocity (261.9 vs. 194.6%, p = 0.005), lumenal area (111.8 vs
104.2%, P = 0.01). peak volumetric blood flow (515.8 vs. 317.2 cc/min, p =
0.007) and coronary flow reserve (2.93 ± 0.79 vs. 1.99 ± 0.56, p < 0.001)
were higher with adenosine compared to dipyridamole. Epicardial dilation
was only seen with adenosine administration (p = 0.01). Both agents caused
similar decreases in systemic blood pressure and little change in heart rate.
Conclusion: Transplant recipients appear to have diminished flow velocity
and flow reserve in response to endothelium-independent agents. Adeno-
sine appears to be a more potent coronary vasodilator than dipyridamole in
denervated human transplant subjects at both the epicardial and microvascu-
lar level at standard doses. Adenosine's effects in the conductance vascula-
ture may be unique to the transplant recipient where denervation is present.
